| Serial Number | 79418518 |
| Word Mark | CORENGAGER |
| Filing Date | Wednesday, November 20, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Thursday, January 8, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Protein in raw material form for scientific and medical research; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biological preparations for use in cell cultures, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; diagnostic preparations for research laboratory use; biological preparations, for use in scientific research and development, other than for medical or veterinary purposes; biochemical reagents used for non-medical purposes; cell culture reagents for scientific or research purposes |
| Goods and Services | Pharmaceutical preparations for detecting, analyzing, diagnosing and treating tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; anti-cancer preparations; diagnostic preparations for medical or veterinary purposes; medicines for human purposes, namely, medicines for detecting, analyzing, diagnosing and treating tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; surgical implants comprised of living tissues; stem cells for medical purposes; vaccines; enzymes for medical purposes; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic diseases, immune disorder, TORCH infections and immunoglobulin diseases, infectious diseases, immune disease and fibrosis diseases |
| Goods and Services | Chemical research; chemical analysis; chemical diagnosis for scientific or medical purposes in the nature of chemical analysis; development and testing of chemical production methods; chemical testing and chemistry consultation services; cosmetic research; bacteriological research; biological research; medical research; medical laboratory services, namely, for research, development, testing, and analysis purposes; clinical trials services for others, including the design, management, monitoring, data management, analysis, reporting, and regulatory compliance of clinical trials |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 21, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 21, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 21, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Corregene Biotechnology Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, March 6, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 21, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, March 21, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 21, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, May 13, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, May 20, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 21, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, July 13, 2025 | REFUSAL PROCESSED BY MPU |
| Sunday, July 13, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, August 2, 2025 | REFUSAL PROCESSED BY IB |
| Thursday, January 8, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 8, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 8, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |